PathAI

Attending #EASLCongress 2024? Visit PathAI at Booth 0-5 and schedule time to connect with us during the conference! Reach out to us: bd@pathai.com #AI #pathology #digitalpathology #biotech

We’re headed to #ASCO24 May 31 - June 4 in Chicago, IL! Will you be at ASCO too? Schedule a meeting with our team to discuss how AI-powered #pathology can fuel your #cancerresearch: https://lnkd.in/emjjbRQC Visit us at our booth in the Innovation Hub (IH18) to learn more about our new partnerships, the PLUTO #FoundationModel, and other exciting #AI developments for your #oncology programs. Stay tuned for more exciting updates! #clinicaldevelopment #translationalresearch #precisionmedicine #digitalpathology

This #WorldIBDDay, PathAI recognizes those facing the everyday challenges of Ulcerative Colitis and Crohn’s Disease – as well as the important work being done to develop more effective treatments for those with #IBD.  https://worldibdday.org/ Today, Inflammatory Bowel Disease has no cure, and incidence rate for this life-altering condition is rising worldwide. Only by expanding our understanding of IBD and its effects can we alleviate the burden it has on our family, friends, neighbors, and communities. #biotech #pathology #DDW2024 #AI

#DDW2024 Attendees: We’ve made additional seats available at our dinner in collaboration with the FNIH this upcoming Sunday evening! If you’re interested in learning more from our panel discussion on standardizing histology endpoint assessment for ulcerative colitis #drugdevelopment, register for the dinner here: https://lnkd.in/eFXHyBJr #biotech #biotechnology #pathology #clinicaldevelopment #IBD

During our IBD Explore webinar last week, Christina Jayson, Ph.D., presented exciting updates on our recent research and how it's impacting our understanding of IBD. https://lnkd.in/d62fatr4 Reach out if you’re ready to learn more about how IBD Explore can transform your clinical development program!

We are thrilled to welcome Mary T. Padilla, M.D., who will lead our Clinical Development Services business for #biopharma, to PathAI on June 1, 2024. Dr. Padilla brings a wealth of experience in #clinicaldevelopment, laboratory operations & diagnostic tool development and will spearhead integration of biopharma lab services, digital pathology, #AI, and #pathology expertise to support prospective clinical studies. "Drawing from her extensive expertise in pathology and clinical development with leading organizations, Dr. Padilla is well-positioned to scale our organization. Her guidance will be instrumental in driving forward our clinical trials business into its next phase of expansion," said Matt Grow, Chief Business Officer & President of Biopharma. Learn more about Dr. Padilla in our latest press release: https://lnkd.in/eznU3vhy

Today, we shared our pre-print describing our new Foundation Model, PLUTO, to fuel #drugdevelopment & #cancerresearch for fast, efficient, and powerful representation of #pathology images. This model was developed and trained on a broad, highly diverse dataset using novel self-supervised training and can be adapted to handle a wide range of pathology tasks at different scales. Read the publication: https://lnkd.in/ewkaGj3D #FoundationModels usher in a new era of #MachineLearning and allow the development of new AI products that are able to tackle a wide diversity of tasks with state-of-the-art performance. PLUTO builds on this with an approach and capabilities tailored to computational pathology, resulting in a model that is better, faster, and more efficient to deploy. The PathoLogy Universal TransfOrmer (PLUTO) is a foundation model trained on a diverse dataset composed of: - Nearly 200 million “image” patches collected from >150,000 whole slide images  - >4 million pathologist annotations to ensure high-quality data and guide image sampling across a wide diversity of substances - Over 30+ disease areas and numerous histologies - Multiple scanners, magnifications, stains, and sources of the data By enabling data- and compute-efficient computational pathology workflows, PLUTO accelerates building #AI powered pathology tools for multiple scales and resolutions to meet the growing needs of researchers, clinicians, and patients.

PathAI is excited to announce the publication of PLUTO, our #pathology centric, efficient #foundationmodel meticulously developed with the aim to fuel research efforts and support our mission to improve patient outcomes with AI-powered tools for #PrecisionMedicine and #CancerResearch. https://lnkd.in/eAB-Z2Q3 PLUTO embodies a flexible multi-resolution architecture for improved and accelerated performance on a range of pathology applications by capturing biological insights from multiple scales - slides, tissue, cellular, and subcellular - for highly scalable biomarker and #drugdiscovery, AI tool development and inference. Read the publication: https://lnkd.in/ewkaGj3D #biotech #AI #drugdiscovery #foundationmodel

🎉 We are delighted to share that our General Counsel Chris Kirby was highlighted as one of Boston's Best: 19 Healthcare Operators to Watch selected by Primary Venture Partners 🎉 Chris leads with humility and courage, bringing to bear two decades of experience in #healthcare and #lifesciences to propel us on our mission. Congratulations Chris! We are honored to have you on our team! Learn more about Chris in this latest feature: https://lnkd.in/gvPf434w

Attending Digestive Disease Week #DDW2024 in Washington, D.C next week? Schedule time to meet with PathAI to discuss how AI-powered digital #pathology solutions can supercharge your #IBD clinical development programs Email us: bd@pathai.com Learn more about the event: https://ddw.org/ #AI #biotech #DigestiveDiseaseWeek #DDW #Ulcerativecolitis